Literature DB >> 3459131

Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.

N L Koven, M M Clark, C S Cody, C A Stanley, L Baker, S D Douglas.   

Abstract

Polymorphonuclear leukocyte (PMN) function was investigated in two patients with glycogen storage disease type IB and neutropenia. Glycogen storage disease type IB was documented by liver biopsy and a normal amount of latent glucose-6-phosphatase activity. Patient A had stomatitis, skin infections, and septicemia; patient B had respiratory infections, periodontitis, and oral candidiasis. Absolute neutrophil counts ranged from 114 to 2580/mm3. Diminished and delayed migration of PMN into a skin "window" occurred in B. Random and directed PMN migration under agarose toward f-Met-Leu-Phe, pepstatin A, and zymosan-activated serum were severely diminished in both patients. At 10(-7) M f-Met-Leu-Phe, mean random and directed migration were 52 and 23% (A, n = 3) and 48 and 13% (B, n = 4) of controls. These results were independent of incubation time and chemoattractant concentration. Patients' PMN had diminished quantitative nitroblue tetrazolium reduction compared to controls. B had a significant defect in PMN bactericidal activity with Escherichia coli with less than 0.2 log killing at 2 h. These results further characterize the defect in PMN migration reported by Beaudet et al. (J Pediatr 97:906, 1980). The finding of other abnormalities of PMN function suggests a metabolic defect in the neutrophil which may be related to the microsomal membrane defect in hepatocytes in glycogen storage disease type IB.

Entities:  

Mesh:

Year:  1986        PMID: 3459131     DOI: 10.1203/00006450-198605000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Dental and periodontal manifestations of glycogen storage diseases: a case series of 60 patients.

Authors:  Martin Biosse Duplan; Aurélie Hubert; Elvire Le Norcy; Alice Louzoun; Ariane Perry; Catherine Chaussain; Philippe Labrune
Journal:  J Inherit Metab Dis       Date:  2018-04-16       Impact factor: 4.982

2.  Anaesthetic management of a patient with glycogen storage disease type 1b.

Authors:  Z Shenkman; Y Golub; S Meretyk; Y Shir; D Landau; E H Landau
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b.

Authors:  L Kilpatrick; B Z Garty; K F Lundquist; K Hunter; C A Stanley; L Baker; S D Douglas; H M Korchak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.